In summary, detailed mechanistic insights into Pdk4 and MIF highlight their critical roles in cardiac metabolism and their potential as therapeutic targets for improving cardiac outcomes in the elderly post-MI (as shown in Figure 1). This evidence concerns the gene PDK4 and myocardial infarction.